DelveInsight

DelveInsight is a leading Business Consulting and Market Research Firm. They combine industry expertise with probing market insights in innovative ways to deliver critical information to leading decision makers. DelveInsight helps their clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledgeable partner for business strategy and market research across the drug value chain.

DelveInsight provides the intelligent information to Business and Healthcare professionals through the analytical and strategic Reports. Currently they have 3000+ Marketed and Pipeline Reports in the Market. These Reports are based on Indication, Mechanism of Actions, Drugs, Global API Manufacturers and Specialized Reports on Onco-Immunology, Orphan Diseases, Biologics & Biosimilars, Gene Therapy, Stem Cells Therapy and other upcoming areas. This platform is used by many companies to transform and redefine their businesses.

DelveInsight deals in Consulting Projects & Competitive Intelligence. In addition to this, they also provides custom research services in coherence with interest area of the clients.


...Show More ...Show Less

3406 Reports from DelveInsight

   
  • Bipolar Depression-Market Insights, Epidemiology, and Market Forecast–2030

    ... EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. The Bipolar Depression market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM Bipolar Depression ... Read More

  • Cystic Fibrosis (CF) – Market Insights, Epidemiology, and Market Forecast – 2030

    ... in the United States, and EU5 (Germany, Spain, Italy, France, and United Kingdom). The Cystic Fibrosis (CF) market report provides current treatment practices, emerging drugs and their market share of the individual therapies, current and ... Read More

  • Alagille Syndrome (ALGS) - Market Insights, Epidemiology, and Market Forecast - 2030

    ... United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Alagille Syndrome (ALGS) market report provides current treatment practices, emerging drugs and their market share of the individual therapies, current and forecasted ... Read More

  • Malignant Pleural Mesothelioma (MPM)-Market Insights, Epidemiology and Market Forecast—2030

    ... EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan. The MPM market report provides current treatment practices, emerging drugs, MPM market share of the individual therapies, current and forecasted MPM market size from 2017 ... Read More

  • Mydriasis – Market Insights, Epidemiology, and Market Forecast—2030

    ... Spain, Italy, France, and United Kingdom), and Japan. The mydriasis market report provides current treatment practices, emerging drugs and their market share of the individual therapies, current and forecasted Mydriasis symptoms market size from 2017 ... Read More

  • Chronic spontaneous urticaria (CSU) - Market Insights, Epidemiology, and Market Forecast - 2030

    ... in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Chronic spontaneous urticaria (CSU) market report provides current treatment practices, emerging drugs and their market share of the individual therapies, ... Read More

  • Bipolar Depression - Epidemiology Forecast - 2030

    ... and the United Kingdom) and Japan. Bipolar Depression Disease Understanding Bipolar disorder (BD), previously known as manic depressive illness or manic depression, is a mental disorder characterized by wide mood swings from high (manic) to ... Read More

  • Mydriasis - Epidemiology Forecast - 2030

    ... Disease Understanding Mydriasis is the dilation of the pupil, which may be due to a non-physiological cause such as disease, trauma, drugs usage, or physiological pupillary response. Mydriatic agents are used to dilation of the ... Read More

  • Celiac Disease (CD) - Market Insights, Epidemiology and Market Forecast– 2030

    ... market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Celiac Disease (CD) market report provides current treatment practices, emerging drugs, and market share of the individual therapies, ... Read More

  • Celiac Disease (CD) - Epidemiology Forecast – 2030

    ... and United Kingdom) and Japan. Celiac Disease (CD) Understanding Celiac Disease (CD)—also known by coeliac disease, celiac sprue, non-tropical sprue, and gluten-sensitive enteropathy—is a chronic, immune-mediated enteropathy in which dietary gluten triggers an inflammatory reaction ... Read More

  • Cystic Fibrosis (CF) - Epidemiology Forecast - 2030

    ... Cystic Fibrosis (CF) Disease Understanding First identified nearly 80 years ago, cystic fibrosis (CF) is an autosomal recessive genetic disorder that causes damage to the lungs and the digestive system with the highest prevalence in ... Read More

  • Alagille syndrome – Epidemiology Forecast—2030

    ... Japan. Alagille syndrome Disease Understanding Alagille syndrome is a genetic disorder that is caused by a mutation in either JAG1 or NOTCH 2 gene. These genes are located on chromosomes 20 and 1, respectively; this ... Read More

  • Malignant Pleural Mesothelioma (MPM)- Epidemiology Forecast to 2030

    ... Spain, and the United Kingdom), and Japan. Malignant Pleural Mesothelioma (MPM) Understanding Mesothelioma is a rare, aggressive form of malignant tumor that is caused by inhaled asbestos fibers and forms in the lining of the ... Read More

  • Chronic spontaneous urticaria (CSU) - Epidemiology Forecast - 2030

    ... the United Kingdom), and Japan. Chronic spontaneous urticaria (CSU) Disease Understanding Chronic urticaria is a debilitating disease that is characterized by itching and hives with or without angioedema, lasting for more than 6 weeks. Chronic ... Read More

  • 5-HT6 Antagonist -Pipeline Insight, 2020

    ... is provided, which includes the topic overview and 5-HT6 Antagonist mechanism of action. The assessment part of the report embraces, in-depth 5-HT6 Antagonist commercial assessment and clinical assessment of the pipeline products under development. In ... Read More

  • 5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) -Pipeline Insight, 2020

    ... Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) pipeline landscape is provided, which includes the topic overview and 5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) mechanism of action. The assessment part of the report embraces, in-depth 5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) ... Read More

  • Adenosine A1 Receptor Antagonist -Pipeline Insight, 2020

    ... Receptor Antagonist pipeline landscape is provided, which includes the topic overview and Adenosine A1 Receptor Antagonist mechanism of action. The assessment part of the report embraces, in-depth Adenosine A1 Receptor Antagonist commercial assessment and clinical ... Read More

  • Adenosine A2 Receptor Antagonist -Pipeline Insight, 2020

    ... Receptor Antagonist pipeline landscape is provided, which includes the topic overview and Adenosine A2 Receptor Antagonist mechanism of action. The assessment part of the report embraces, in-depth Adenosine A2 Receptor Antagonist commercial assessment and clinical ... Read More

  • Adenosine A2A Receptor Agonist -Pipeline Insight, 2020

    ... Receptor Agonist pipeline landscape is provided, which includes the topic overview and Adenosine A2A Receptor Agonist mechanism of action. The assessment part of the report embraces, in-depth Adenosine A2A Receptor Agonist commercial assessment and clinical ... Read More

  • Adenosine A2A Receptor Antagonist -Pipeline Insight, 2020

    ... Receptor Antagonist pipeline landscape is provided, which includes the topic overview and Adenosine A2A Receptor Antagonist mechanism of action. The assessment part of the report embraces, in-depth Adenosine A2A Receptor Antagonist commercial assessment and clinical ... Read More

  • Adenosine A3 Receptor Antagonist -Pipeline Insight, 2020

    ... Receptor Antagonist pipeline landscape is provided, which includes the topic overview and Adenosine A3 Receptor Antagonist mechanism of action. The assessment part of the report embraces, in-depth Adenosine A3 Receptor Antagonist commercial assessment and clinical ... Read More

  • Adrenergic Uptake Inhibitor -Pipeline Insight, 2020

    ... pipeline landscape is provided, which includes the topic overview and Adrenergic Uptake Inhibitor mechanism of action. The assessment part of the report embraces, in-depth Adrenergic Uptake Inhibitor commercial assessment and clinical assessment of the pipeline ... Read More

  • Aldosterone Antagonist -Pipeline Insight, 2020

    ... is provided, which includes the topic overview and Aldosterone Antagonist mechanism of action. The assessment part of the report embraces, in-depth Aldosterone Antagonist commercial assessment and clinical assessment of the pipeline products under development. In ... Read More

  • Alpha Glucosidase Inhibitor -Pipeline Insight, 2020

    ... pipeline landscape is provided, which includes the topic overview and Alpha Glucosidase Inhibitor mechanism of action. The assessment part of the report embraces, in-depth Alpha Glucosidase Inhibitor commercial assessment and clinical assessment of the pipeline ... Read More

  • Alpha v Beta 5 Integrin Antagonist -Pipeline Insight, 2020

    ... Alpha v Beta 5 Integrin Antagonist pipeline landscape is provided, which includes the topic overview and Alpha v Beta 5 Integrin Antagonist mechanism of action. The assessment part of the report embraces, in-depth Alpha v ... Read More

< prev 1 3 4 5 6 7 8 9 10

Research Assistance

Join Alert Me Now!

Sign Up

Find out more on our blog

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook